Tagged with US

Array The managing director of Brussels Invest & Export discusses Belgium’s unique attractiveness when it comes to the life sciences, and which countries and companies are interested in investing in the pharmaceutical sector in the country and why.    After its creation in 2003, Invest in Brussels joined forces with Brussels…

Biopark Charleroi Brussels South Could you tell our readers who are not familiar with the Biopark with an introduction of the Biopark and its institutes? The BioPark of Charleroi Brussels South is a campus where major biomedical research infrastructures of the Université Libre de Bruxelles (ULB) have been established since 1999. It was a…

Pfizer Austria Dr. Rumler, what is your assessment of the subsidiary’s current strengths and weaknesses, after three and half years of tenure? Pfizer currently ranks second in the overall pharmaceutical market in Austria, just behind Novartis, which includes its subsidiaries Sandoz, Hexal, and 1A Pharma. Our focus clearly lies on country customer…

Boehringer Ingelheim Austria Austria has always been a strategic market for the group: it has played a key role in Boehringer Ingelheim’s success story, as this is where the company established its first foreign subsidiary in 1948. Can you give our readers a snapshot of the strategic importance Austria has today for the…

Teva Ratiopharm Austria Dr Spatz, what would you highlight as the main specificities of the Austrian generic market, and explain how Teva has adapted its approach to the Austrian environment? Teva recently changed directions in its development, determined to be a multifaceted company, offering to the market not only generics but also branded…

Business & Decision Life Sciences Business & Decision Life Science was founded back in 2007, although that department existed within the group’s structure long before that. Could you highlight the reasons why a special business unit dedicated to the life sciences industry needed to be created back in 2007? Founded in 1992, Business & Decisions…

Menarini Austria Dr. Nikitsch, you started Menarini’s Austrian operations almost 13 years ago. Would you say that Menarini’s presence in Austria today reflects the vision you had for the company in Austria at its creation? I would go beyond this statement and say that Menarini Austria is more today than we expected…

Austroplant Arzneimittel Can you give our readers a snapshot of Austroplant’s scope of activities and its structure in Austria and the central European market? Austroplant/Dr Peithner belongs to the Schwabe Group, the worldwide leader in herbal medicine products. It was sold to the Schwabe Group as a family business in 2009. Dr.…

Merck Austria Dr Prchla, you have been heading Merck’s Austrian subsidiary over the past eighteen months. What do you see as the key strengths of your company today? Mirroring the company’s structure, the Austrian affiliate gathers several divisions under one roof. Merck Serono is the largest division of Merck Austria: it markets…

Pharmacy Guild Australia Would you please introduce The Pharmacy Guild to our readers, giving an insight in its function and its membership? We are the premium body representing community pharmacies in Australia, about 5200 locations including private hospital pharmacies. In reality it is safe to say that we represent all pharmacies that are…

Astellas Austria Whereas most General Managers are exposed to different countries during their professional career, you have chosen to dedicate yours to the Austrian market. What is it in this country so unique that has kept you here over the years? It is a very good question. Since 1974, I have worked…

Medicines Australia We last met you in 2008 as Chair of the Pharmaceuticals Industry Council (PIC), which set itself the goal of doubling the levels of exports, R&D investment, manufacturing, value-added activities, and clinical trials from 2002 to 2012. Are you content looking at the achievements today? Exports still stand at about…